Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
High efficiency vs. the personal connection: Experts debate the future of telemedicine
Telemedicine offers the promise of increased efficiency during patient care, but in-person evaluations and relationships are too valuable to completely disregard, according to a debate session at EULAR 2022 Congress.
VIDEO: Sleep, depression, age can predict future cognitive impairment
CHARLOTTE, N.C. – Researchers found that sleep variability, depression and age significantly predicted cognitive impairment at 10 years, according to a study presented here at SLEEP 2022.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Sleep difficulties common after COVID-19 infection
CHARLOTTE, N.C. – Sleep disturbances were found to be highly prevalent and pervasive in patients with post-acute sequelae of COVID-19, Cinthya Pena Orbea, MD, said at the SLEEP meeting.
VIDEO: Immunoglobulin therapy may play a role in treating COVID-19
NEW ORLEANS – Autopsy results in otherwise healthy people who died from COVID-19 suggest that immunoglobulin therapy may be an effective treatment choice, Avindra Nath, MD, said at the American Psychiatric Association annual meeting.
Consider COVID-19 history when addressing sleep deprivation
CHARLOTTE, N.C. — A history of COVID-19 nearly doubled the odds of having very short sleep, according to results from a large U.S. study presented at SLEEP 2022.
Pupil reflex may help identify hyperarousal in insomnia
CHARLOTTE, N.C. — Pupillary light reflex testing may hold potential in detecting a hyperarousal subtype of patients with insomnia, William Vaughn McCall, MD, said at the SLEEP 2022 meeting.
Sleep apnea has complex role in cardiovascular disease
CHARLOTTE, N.C. — The link between sleep apnea and cardiovascular disease involves multiple pathways and outcomes, Susan Redline, MD, MPH, Peter C. Farrell Professor of Sleep Medicine at Harvard Medical School, said at SLEEP 2022.
Non-urban stroke patients in New Zealand face poorer outcomes, lack critical care
Patients treated for stroke at non-urban hospitals in New Zealand experience poorer outcomes and face reduced access to crucial stroke interventions across the entire care spectrum, according to a study published in Neurology.
FDA extends NDA review for ALS drug
The FDA has extended its new drug application review of AMX0035, a combination of sodium phenylbutyrate and taurursodiol for the treatment of ALS, Amylyx Pharmaceuticals Inc. announced in a press release.
Disparities in filled opioid use disorder prescriptions linked to COVID-19 pandemic
The COVID-19 pandemic was a likely cause for worsened disparities in buprenorphine and naltrexone access for opioid use disorder among minority groups compared with white patients, per a study published in JAMA Network Open.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read